Please provide your email address to receive an email when new articles are posted on . Disease progression occurred in more patients receiving placebo vs. an oral lysophosphatidic acid receptor 1 ...

Pregnancy post-glioma diagnosis is associated with worse progression-free survival, but no deterioration occurs during pregnancy itself. Patients who had children after glioma diagnosis showed a 2.45 ...

Sarclisa, Velcade, Revlimid and dexamethasone improved progression-free survival in patients with multiple myeloma who were not eligible for transplant. A new drug combination called Isa-VRd was ...

ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) today announced the phase 3 METIS clinical trial met its primary endpoint, demonstrating a statistically significant improvement in time to ...